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Abstract
Background: Rapid means to discover and enumerate unknown mutations in the exons of human
genes on a pangenomic scale are needed to discover the genes carrying inherited risk for common
diseases or the genes in which somatic mutations are required for clonal diseases such as
atherosclerosis and cancers. The method of constant denaturing capillary electrophoresis (CDCE)
permitted sensitive detection and enumeration of unknown point mutations but labor-intensive
optimization procedures for each exonic sequence made it impractical for application at a
pangenomic scale.
Results: A variant denaturing capillary electrophoresis protocol, cycling temperature capillary
electrophoresis (CTCE), has eliminated the need for the laboratory optimization of separation
conditions for each target sequence. Here are reported the separation of wild type mutant
homoduplexes from wild type/mutant heteroduplexes for 27 randomly chosen target sequences
without any laboratory optimization steps. Calculation of the equilibrium melting map of each
target sequence attached to a high melting domain (clamp) was sufficient to design the analyte
sequence and predict the expected degree of resolution.
Conclusion: CTCE provides practical means for economical pangenomic detection and
enumeration of point mutations in large-scale human case/control cohort studies. We estimate that
the combined reagent, instrumentation and labor costs for scanning the ~250,000 exons and splice
sites of the ~25,000 human protein-coding genes using automated CTCE instruments in 100 case
cohorts of 10,000 individuals each are now less than U.S. $500 million, less than U.S. $500 per
person.
Background
Enumeration and discovery of statistically significant dif-
ferences in the sum of all point mutations in the exons
and splice sites of each known gene in large case and con-
trol cohorts can identify a large fraction of genes carrying
inherited risk for common disease. This approach does
not depend on the assumption of mono-allelic risk and is
therefore independent of the method of linkage disequi-
librium analysis [1]. Constant denaturing capillary elec-
trophoresis (CDCE) permits separation and sensitive
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within exon-sized target sequences and is to date the only
mutation scanning technology demonstrated to permit
unknown mutant enumeration in pooled DNA samples
of 100 to 10,000 individuals [2,3]. In analyses employing
CDCE, target DNA sequences are attached during high
fidelity PCR to fluorescently labeled ~40–60 bp DNA
sequences with melting temperatures of >94°C. These
thermally stable sequences serve as "clamps" that prevent
the dissociation during electrophoresis of the two anti-
parallel stands of less thermally stable DNA (melting tem-
peratures of 60–80°C) containing the target sequence.
Simple melting and cooling of the PCR products converts
rare mutant sequences into mutant/wild type heterodu-
plexes while capturing the numerically predominant wild
type sequences as homoduplexes. The wild type homodu-
plexes are separated from all mutant-containing heter-
oduplexes based on differential average migration
velocities on capillary gel electrophoresis at a column
temperature optimized for each target sequence. Individ-
ual sequences are isolated as eluting peaks and subse-
quently identified by DNA sequencing.
However, CDCE separations are dependent on coopera-
tive equilibria governing melting and annealing reactions
in stringently defined target sequences comprising single
isomelting domains, i.e. a DNA sequence of ~100 bp in
which the melting temperature is essentially invariant
with sequence (+/-0.15°C). CDCE does not detect all
point mutations in target sequences that are not single iso-
melting domains; sequences comprising exons and adja-
cent intronic splice sites (exonic sequences) frequently
comprise two isomelting domains or more irregular melt-
ing domains. The optimal CDCE separation temperature
is generally found to be near the calculated melting tem-
perature of the wild type homoduplex's isomelting
domain. But satisfactory separation of all mutant
sequences, especially the single base insertion or deletion
mutations that minimally perturb the annealed heterodu-
plex, requires definition of optimal separation tempera-
ture within +/-0.1°C. Time-consuming trial and error
optimization steps for each target sequence account for
about 95% of the labor costs of assay for mutations in
large human population samples [2,3]. Development of a
set of CDCE assays for the multiple exons of a typical gene
typically consume about four months for an experienced
researcher. Furthermore, CDCE separations are excruciat-
ingly sensitive to temperature variations requiring instru-
ments capable of day-to-day reproducibility of +/-0.1°C.
Under these conditions application of CDCE to the
~250,000 exons of the human genome would be a formi-
dable task involving some 12,500 years of technical labor
for optimization alone. Fortunately, these three technical
limitations of CDCE have been overcome by the discovery
that when the capillary temperature is cycled by several
degrees Celsius, e.g. +/-6°C, that includes the calculated
average melting temperature of any consensus target
sequence, separations of homoduplexes and wild type/
mutant heteroduplexes are achieved equivalent in peak
resolution to optimized constant-temperature CDCE con-
ditions [4-7]. The temperature cycling protocol obviates
the need for stringent temperature control. Point muta-
tions within target sequences with irregular melting
domains are reliably detected. Most importantly, the
desired degree of wild type-mutant separations is achieved
without any prior optimization steps: the computer
assisted design of the target sequence with attached high
melting domain "clamp" is sufficient to define an analyte
configuration suitable for separations on CTCE.
Results
Relationship of mean target melting temperature to 
optimal separation temperature
Each wild type and mutant sequence was amplified by
PCR and approximately equal numbers of each molecule
were mixed heated to melt the homoduplexes and cooled
to form a mixture of the four expected duplexes: the wild
type homoduplex, the mutant homoduplex and the two
wild type/mutant heteroduplexes. Using these admixtures
of DNA duplexes the effects on peak resolution of mean
cycle temperature were studied relative to the average
melting temperature of the wild type homoduplex.
Figure 3A shows as an example the degree of separation of
the two polymorphic homoduplexes and the two heter-
oduplexes of target #1 derived from the gene BRCA1. The
separation shown (Figure 3A) was achieved at the mean
column temperature of 48.5°C in 7 M urea using twenty
one-minute temperature cycles of amplitude 3°C. Target
sequence #1 has a calculated mean melting temperature
of 70.7°C at physiological salt conditions and about
49.7°C (70.7-21°C) in 7 M urea. Seventeen mean temper-
atures with 3°C amplitudes were tested in one degree Cel-
sius increments from 41.5 to 57.5°C and the degree of
separations observed as shown in Figure 3B. Separation
was expressed as the number of seconds elapsed between
any two peaks. The most rapidly eluting peak 1 contained
the wild type homoduplex, peak 2 the mutant homodu-
plex and peaks 3 and 4 the two mutant/wild type heter-
oduplexes eluting in inverse order of mean melting
temperature of the duplexes. At 41.5°C, no separations
were observed. Significant separations of the wild type
homoduplex and more stable heteroduplex (peak 3) were
evident at 43.5°C, with the maximum separation
observed at about 48.5°C. The degree of separation
declined with an increase in mean cycle temperature from
48.5°C to 52.5°C, and then decreased more slowly up to
57.5°C, the maximum mean column temperature tested.Page 2 of 10
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mutant-containing heteroduplexes are separated by CTCE
even when the mean temperature during cycling is devi-
ates by +/-1.5°C from the optimal separation tempera-
ture. It appeared that the mean cycling temperature could
be set close (+/-1.5°C) to the calculated mean melting
temperature for a target wild type homoduplex to achieve
near optimal separation of wild type homoduplex and
derived mutant/wild type heteroduplexes. We subse-
quently tested this conclusion by extending our observa-
tions these observations to target sequences #2 through
#12. All target sequences displayed separation optima
near their calculated melting temperatures, with baseline
separation of all mutant/wild-type heteroduplexes from
the wild type homoduplexes within a range of +/-1.5°C of
the optimum temperature for each target sequence. No
laboratory optimization of separation conditions
appeared to be required.
Number and duration of cycles required for separation
We next explored reducing the number of temperature
cycles with the aim of minimizing the time required per
separation, a matter of importance in considering a pang-
enomic scanning effort. Accordingly, 7, 12, 17 and 20
one-minute cycles of 3°C amplitude were employed for
fragments #2, 9, 10 and 12, using their mean calculated
melting temperatures in urea (7 M) of 48.6, 48.2, 48.5,
and 46.7°C, respectively. Using the time of separation
between the less stable homoduplex and more stable
mutant/wild type heteroduplex, we observed linear
increases in the degree of separation of fragments #2, 9
and 12 with increasing cycle number, whereas fragment
#12 displayed a somewhat supralinear relationship with
cycle number as shown in Figure 4. As few as seven 1-min
cycles of 3°C achieved a minimum 1-min separation of
the less stable homoduplex and more stable heterodu-
plex. These observations that relatively few temperature
Distribution of mean melting temperatures of all known exonic sequences in the human genomeFigure 1
Distribution of mean melting temperatures of all known exonic sequences in the human genome. Based on the melting profiles 
created by a PubGene-MIT-Beckman Coulter collaboration, the histogram comprises the melting temperatures of all 236,039 
exonic sequences from a set of human 27,561 protein encoding genes derived by Ensembl, a joint project of EMBL-EBI and the 
Sanger Institute. The resolution is 0.1°C. Mean temperatures were calculated for each exon plus 50 intronic base pairs 3' and 
5' to each exon to include mRNA splice sites. (Reproduced with permission of PubGene, Inc.).Page 3 of 10
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value in the performance of a truly high-throughput task,
such as detecting all point mutations of the ~250,000
human exonic sequences in a million persons.
A high throughput parallel 10,000 capillary CDCE instru-
ment, such as the one under construction at MIT, presents
challenge of cycling temperature by 3°C in one minute by
fluid flow in a relatively large (~5 l) capillary chamber. We
therefore explored the tactic of increasing the amplitude
of each cycle to 12°C, which reduced the number of cycles
to five in a twenty-minute capillary separation. The data
for octuplicate trials of each of twelve target sequences
(#1–#12) separated in a capillary run five four-minute
cycles of 12°C amplitude (47–59°C) are summarized in
Figure 5. Under these easily created conditions we discov-
ered that for fragments #1 through #12 that the separation
of the less stable homoduplex from the more stable heter-
oduplex equaled or exceeded that obtained for twenty
one-minute cycles.
Separations of fifteen additional wild type/mutant exonic 
sequences without laboratory optimization
To further test our preliminary conclusion that the degree
of CTCE separation can be reproducibly achieved without
resorting to any form of optimization except for calculat-
ing the target sequence melting temperatures, a second set
of fragments (#13–27) was subjected to five four-minute
cycles of 12°C amplitude (48–60°C). Data from sextupli-
cate runs in separate capillaries are presented in Figure 6
as in Figure 5. Capillary to capillary variation was marked,
as is the case with capillary separations generally. This var-
iation does not interfere with the automatic calculation of
the ratio of the sum of peak areas for peaks eluting after
the predominant wild type homoduplex peak to the sum
of all peaks as an estimate of the fraction of mutant target
copies in a pooled blood DNA sample. All four expected
peaks were clearly resolved with baseline separations for
every one of the twenty-seven target sequences in every
run, including those of fragment #27 with a calculated
melting temperature of 45.6°C, and fragments #17 and
19 with melting temperatures of 55.6°C in 7 M urea.
Discussion
These observations demonstrate that cycling temperature
denaturing capillary electrophoresis (CTCE) represents an
important practical advancement in separation, detection
and enumeration of unknown mutations in sequences of
interest in the human genome. The degrees of separation
obtained with the simple cycling temperature regimens
are equivalent to those achieved using carefully defined
optimal temperatures for each sequence in constant (tem-
perature) denaturing capillary electrophoresis (CDCE).
CTCE removes the practical impediment presented by the
laboratory optimization requirements of CDCE and facil-
itates practical and economic pangenomic exon scanning
to discover genes associated with inherited or somatic
mutations conferring risk or common diseases. Secondly,
CTCE is applicable to exonic sequences comprising two
isomelting domains or an irregular melting profile (Figure
1; Figures 5, 6). So long as the target sequence is con-
structed such that the computationally defined melting
profile consists of a monotonically decreasing melting
temperature from the clamp junction through the ulti-
mate primer sequence, CTCE yields the degree of separa-
tion required for scanning exonic sequences of 100–200
bp for unknown point mutations.
Physical basis of CDCE and CTCE
The physical basis of denaturing gel electrophoretic sepa-
ration of variant DNA sequences has yet to be established.
Lerman and Fischer (1983) [8] initially applied the statis-
tical mechanical reasoning of Poland [9] to the separation
of mutants in a low melting domain naturally juxtaposed
to a higher melting sequence serving as a "clamp" to
achieve separate homoduplexes differing by a single base
The melting profile of three target sequences # 6, 14 and 26 calculated with WinMelt illus rating a w ll-defined target of asingle isomel ing domain (#6),  targ t with two isomeltingdomains (#26) and a targ t with n irregular m lting profile (#16)Fig re 2
The melting profile of three target sequences # 6, 14 and 26 
calculated with WinMelt illustrating a well-defined target of a 
single isomelting domain (#6), a target with two isomelting 
domains (#26) and a target with an irregular melting profile 
(#16). The symbols mark the position of the sequence differ-
ences AT>GC (#6), TA>CG (#14) and TA>CG (#26) in 
each target wild type>mutant pair in separation trials. The 
GC-clamp (~94°C) is not shown but was incorporated in the 
melting calculations attached to the higher melting tempera-
ture end of each target sequence.
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in only two states: melted and annealed. The separations
observed with CTCE conditions appear to require a more
complex explanation invoking multiple pathways for
melting and re-annealing of a DNA duplex molecule and
their interactions as the duplex is subjected to varying
denaturing conditions while being pulled through a poly-
mer matrix by a strong electric field [10]. Heteroduplexes,
but not homoduplexes, contain multiple possible oligo-
nucleotide runs, including a mismatch that destabilizes
melting and annealing that is absent in homoduplexes.
Heteroduplexes may thus maintain a significantly differ-
ent time-average fraction in the slow-moving forms than
homoduplexes throughout a large proportion of the tem-
perature cycle under these non-equilibrium conditions.
Practical application of CTCE in high-throughput tasks
We have recently reported the application of CDCE to
analysis of exons, splice sites of all exons, and splice sites
of two genes, CTLA4 and HBB, in large (~78,000 person)
human population samples. The temperature optimiza-
tion and stringent temperature control steps presented a
major time and cost issue (~95% of labor costs) that
would be severely limiting in a strategy that requires scan-
ning the ~250,000 exonic sequences of the human
genome [2,3].
Analysis of human somatic and/or inherited point muta-
tions is important in both population genetics and clini-
cal practice. In population genetics, such analyses are
required to identify genes that carry mutations defining
risks for a particular disease in families (rare diseases) or
large general populations (common diseases). Once the
genes and sets of risk-conferring mutations in a popula-
tion are defined, clinical genetic analyses may be per-
formed for individual patients to aid in diagnosis,
determine the optimal form of therapy or provide more
accurate prognosis.
Morgenthaler and Thilly [1] have argued that discovery of
a gene or genes that carry point mutations conferring risk
for common diseases may be achieved by pangenomic
Illustration of peak resolution in CTCEFigu e 3
Illustration of peak resolution in CTCE. A. Separation of homoduplexes and heteroduplexes as electophoretic peaks using tar-
get sequence #1 from the gene BRCA1. The melting profile was irregular with a mean melting temperature of 70.7°C for the 
wild type homoduplex (peak 1). Twenty one-minute temperature cycles between 47°C and 59°C yielded baseline separations 
between homoduplexes and heteroduplexes. Small diffuse peaks result from errors generated during PCR with low-fidelity Taq 
polymerase and chemical reactions, such as thermal deamination of cytosine. These are avoided in mutation detection proto-
cols that minimize the effect of deamination and employ Pfu DNA polymerase which does not copy passed a deaminated cyto-
sine (uracil). B. Effect of mean column temperature on peak resolution. Temperature was varied in twenty one-minute cycles 
with 3°C amplitude and mean temperatures varying from 41.5 to 57.5°C.Page 5 of 10
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control cohort trials. Accounting for a series of confound-
ing variables including multigenic and multiallelic condi-
tions of risk they prescribed an effort to scan the exons
and splice sites of ~25,000 human genes to enumerate
mutations in population samples of 10,000 afflicted per-
sons for each of the ~100 common diseases. This involves
some 2.5 million pair wise gene-disease trials. To accom-
plish a pangenomic scan for inherited mutations associ-
ated with risk for common diseases in one million
individuals, a method is required that effectively scans all
the function-encoding domains of a gene, rarely fails to
detect a point mutation, and permits high-throughput
economical studies in a large number of genes and peo-
ple.
Several methods have been devised to detect unknown
DNA variants, based on differential migration velocities
of mutant single-strand sequences or wild-type/mutant
heteroduplexes drawn through a macromolecular matrix
by an electric field [11-13]. Of these, only CDCE under
optimized conditions has permitted the comprehensive
detection of point mutations in pooled blood DNA sam-
ples from 100 to 10,000 persons [2,14].
Using an estimate of 400,000 target genomic sequences,
CTCE scanning of case cohorts of 10,000 individuals each
for the 100 most important human diseases with familial
risk factors becomes a practical possibility. This involves
scanning point mutations in 2 allelic copies per person ×
106 persons × 400,000 exonic fragments per genome = 8 ×
1011 exonic fragments. Pooling DNA for each fragment
from 100 persons within each case cohort would require
about 4 × 109 capillary runs. With automatic loading and
CTCE separation/gel replacement cycles of ~30 min, a
well-engineered facility might be expected to achieve ~48
runs per capillary/day. With one hundred 10,000-capil-
lary instruments ~4.8 × 107 pooled samples may be proc-
essed per day. The "task" of screening 4 × 109 pooled
samples would require 4 × 109/4.8 × 107 = 84 days. Ten
instruments would complete the task in a more leisurely
840 days. Using either strategy, we estimate that collecting
and processing samples from an ensemble of 100 disease-
specific cohorts of 10,000 individuals each (including
sample collection, sample processing, and CTCE analysis)
can be performed for less than half a billion US dollars.
This amounts to less than U.S. $500 per person to identify
and enumerate the mutations carried by exons and splice
sites of one million individuals distributed over any 100
important diseases that are possibly affected by inherited
risk factors. The melting map for the entire human
genome [15] is now available. CTCE makes it practical to
scan for point mutations in the human population.
Conclusion
CTCE provides practical means for economical pang-
enomic detection and enumeration of point mutations in
large-scale human case/control cohort studies. We esti-
mate that the combined reagent, instrumentation and
labor costs for scanning the ~250,000 exons and splice
sites of the ~25,000 human protein-coding genes using
automated CTCE instruments in 100 case cohorts of
10,000 individuals each are now less than U.S. $500 mil-
lion, less than U.S. $500 per person.
Methods
Choice of target sequences
We wished to choose target sequences to test the proposi-
tion that human exonic target sequences could be scanned
for point mutations by CTCE without laboratory optimi-
zation steps. We began with the determination of the aver-
age melting temperatures of the known 236,069 exonic
sequences of the human genome performed and reported
by PubGene, Inc. (Oslo, Norway) shown as a distribution
of the number of exons over average melting temperatures
in Figure 1. Exonic sequences (exons + intronic splice
sites) ranged from 60 to 88°C with some 93% having
average melting temperatures less than 80°C, the upper
limit of temperature at which DNA "clamps" are suffi-
ciently stable to permit CDCE or CTCE separations [4]. Of
the 7% of human exons with average melting tempera-
tures greater than 80°C, more than half may be scanned
by the expedient of dividing the target sequence so that all
or most of the sequence may be scanned; we estimate that
some 97% of the human exonic sequences may be inter-
rogated by CTCE. (Note that the melting temperatures for
near-physiological conditions are ~21°C higher than
Separation of the wild type and mutant homoduplexes as a function of number (7, 12, 17 and 20) of one-minute cycles of 3°C amplitude (47°–50°C) for target sequences # 2, 9, 10and 12Figu e 4
Separation of the wild type and mutant homoduplexes as a 
function of number (7, 12, 17 and 20) of one-minute cycles of 
3°C amplitude (47°–50°C) for target sequences # 2, 9, 10 
and 12.
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BMC Genetics 2007, 8:54 http://www.biomedcentral.com/1471-2156/8/54those observed in 7 M urea used in our experiments to
allow separations at temperatures below 60°C.)
We next had recourse to our library of human exonic
sequences carrying a point mutation as a common poly-
morphism. We examined the set of several thousand pos-
sible exons and chose twenty seven simply on the basis of
average melting temperatures ranging from ~66.6 to
78.1°C but without prior knowledge of the behavior on
CTCE. Their identities, sequences and melting characteris-
tics (WinMelt 2.0, Medprobe, Norway) are summarized in
Table 1. By chance, of these twenty seven, six targets com-
prised a single isomelting domain (standard deviation in
melting temperature among base pairs in the target
sequence of less than 0.15°C) that would generally be
expected to permit analysis by CDCE. The remaining
twenty-one sequences comprised either more than one
isomelting domain or an irregular melting profile with a
standard deviation in target sequence melting tempera-
ture ranging from 0.3 – 4.2°C. Such sequences are in gen-
eral not suitable for CDCE-based scanning. Figure 2
illustrates the variety of melting profiles represented
within the set: fragment #6 comprised a single melting
domain, fragment 26 comprised two isomelting domains
differing by ~10°C while fragment #14 displays an irreg-
ular profile ranging in melting temperature over 7°C.
In initial trials of CTCE, separations were unsatisfactory if
a low melting domain of the target sequence were flanked
by the clamp and a target sequence of higher melting tem-
perature.
Thus, clamps were attached at the higher melting temper-
ature end of sequences such as fragments #14 or #26 to
avoid such a configuration. (A target sequence is occasion-
ally encountered with a low melting domain flanked by
higher melting temperature sequences. Such target
sequences are scanned by the expedient of scanning them
as two separate sequences both terminating in the low
melting domain.)
Differences in the CTCE migration times of all peaks relative to the most thermally stable homoduplex for target sequences #1–12Figu  5
Differences in the CTCE migration times of all peaks relative to the most thermally stable homoduplex for target sequences 
#1–12. Five four-minute cycles (20 min) were employed with an amplitude of 12°C (47°C – 59°C). The results are illustrated 
as the average migration time difference +/- 1 standard deviation, n = 8. A representative electropherogram obtained from 
fragment #6 is incorporated to illustrate peak positions.
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Genomic DNA was extracted from anonymous blood
donor samples with a QIAamp DNA Blood Midi Kit (Qia-
gen Inc., Valencia, CA, USA). Primers were designed with
Primer3 software [16] so that all fragments could be
amplified under similar PCR conditions. A 40 base-pair
sequence with a melting temperature of ~94°C and
labeled with 6-FAM was incorporated into one primer
during oligonucleotide synthesis, creating a high melting
domain "clamp" adjacent to the target sequence (Table 1).
Amplification was performed on a PTC-200 thermal
cycler (MJ research, Waltham, MA, USA) by mixing ~50 ng
genomic DNA with 2.5 mmol of each dNTP (Perkin
Elmer, Oslo, Norway), 10 × Taq buffer, 1 unit Taq, 0.1
units of Pfu and 5 pmol of each primer (MedProbe, Oslo,
Norway) in a final volume of 20 μl. The cycling parame-
ters included 35 cycles of denaturation for 30 sec at 94°C,
annealing at 56°C for 30 sec and elongation at 72°C for
1 min, followed by an elongation step of 72°C for 10 min
at the end of the last cycle.
Electrophoresis
A 96-capillary DNA analyzer, MegaBACE™ 1000 DNA
Analysis System (Amersham Biosciences, Uppsala, Swe-
den), was adapted for CTCE separations with software
modifications to control temperature cycling. The dis-
tance from the anode to detector was 40 cm. Linear poly-
acrylamide (MegaBACE LPA) containing 7 M urea was
replaced in capillaries prior to each run. Samples were
loaded into the capillaries from 96-well plates by electrok-
inetic injection at 133 V/cm for 12 seconds. Electrophore-
sis was performed at a constant field of 133 V/cm. Laser-
induced fluorescence was used with excitation at 488 nm
(blue argon laser) and emission at 520 nm (FAM chan-
nel).
Modification of MegaBACE to allow for high temperature 
settings
The instrument was modified by replacing the "tmpr.nxe"
file with an updated version obtained from Molecular
Dynamics (acquired by Amersham Biosciences, which is
Differences in the CTCE migration times of all peaks relative to the most thermally stable homoduplex for target sequences #13–27Figu  6
Differences in the CTCE migration times of all peaks relative to the most thermally stable homoduplex for target sequences 
#13–27. Five four-minute cycles (20 min) were employed with an amplitude of 12°C (48°C – 60°C). The results are illustrated 
as the average migration time difference +/- 1 standard deviation, n = 6.
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necting the cooling fan, and facilitates changes to the tem-
perature limits in the registry. Temperature changes,
which made cycling possible, were made in the
"macro.ini" file under the section [Inject Samples and
Run]. Files and detailed descriptions are available upon
request.
Denaturing conditions and temperature control
The denaturing temperature in the capillary chamber, i.e.
cycling temperature, was programmed in the macro.ini
file of the Instrument Control Manager (ICM) software
package (Amersham Bioscience). Files are available from
the corresponding author upon request. The MegaBACE
instrument permitted a heating/cooling rate of about
0.1°C/second. At this rate of temperature change, we
could observe the degree of separation as a function of
cycle number (5 to 20), mean temperature (41.5 to
57.5°C) and temperature cycle amplitude (3°C to 12°C).
Due to the fixed temperature ramping rate (~0.1°C/sec),
the effective on-column separation time varied as a func-
tion of cycle number and amplitude. Hence, a tempera-
ture range of 3°C created a 60 second cycle, whereas a
cycle with a temperature range of 12°C created a 240 sec-
ond cycle. The MegaBACE Sequence Analyzer software
program (Amersham Bioscience) was employed to meas-
ure the migration times and areas of all peaks.
Authors' contributions
POE carried out the allele separation on the MegaBACE
and wrote the cycling conditions in the macro.ini file.
POE and JB evaluated all the electropherograms and per-
formed the calculations. WGT participated in the design
of the study and performed the statistical analysis. All
authors contributed equally in the writing of the manu-
script and have read and approved the final version.
Table 1: Characteristics of 27 fragments used to test separation of CTCE
# Gene symbol NCBI rs number DNA variant PCR primer 
"Forward" 5'-3'
PCR primer 
"Reverse" 5'-3'
Mean 
melting, °C
Δ mean 
melting, °C
Fragment 
length, bp
1 BRCA1 rs799923 T59C *gtccatggtgtcaagtttct gttggacactgagactggtt 70.7 0.6 147
2 BRCA1 rs16940 T42C *accccaaagatctcatgtta cgagatactttcctgagtgc 68.9 0.4 154
3 MTHFR rs1801133 T28C *catccctattggcaggtt aagaaaagctgcgtgatg 75.3 0.3 159
4 OPSIN ac092402 T51G *tctgtctttgctgcttcac tttagaaaatgcctttggtc 70.6 0.1 159
5 MTHFR rs1801131 A41C *actccagcatcactcact gagctgctgaagatgtgg 73.5 0.5 157
6 MTHFR rs2274976 A35G *ccaggttgaccaggaagt gtgtaggacgaggccttt 75.7 0.3 156
7 CBS rs234706 A45G *ggtgactgaggtgtcagg gacgcaccatcacactg 77.6 0.5 168
8 NQO1 rs1800566 T25C *ctcatcccaaatattctcca tctgtggcttccaagtctta 72.6 0.2 157
9 DPYD rs3918290 A53G *caccaacttatgccaattct tgcatattggtgtcaaagtg 68.3 0.6 138
10 DPYD rs17376848 T43C *caccaacttatgccaattct tgcatattggtgtcaaagtg 69.0 0.3 138
11 DPYD rs1801265 T30C *tcaggatttcttttccaatg atcctcgaacacaaactcat 70.5 0.7 120
12 CTLA-4 rs5742909 T40C *tcgaaaagacaacctcaag aggaaattctccaagtctcc 67.8 0.3 175
13 COL1A1 rs1007086 A64G *ctaaggatgggaggcacga ccccctgtaagtatcactcc 76.5 0.2 132
14 COL1A1 rs1061237 T30C *ttcctgtaaactccctccat tgaaattgtctcccattttt 73.7 0.2 164
15 COL1A1 rs2857401 T54G *ctgagatggcagttcttga ctaaatgtctgttccctcca 74.1 0.2 155
16 COL1A1 rs2249492 T68C *catagtgccctctctccat gaggtcttggtggttttgta 76.0 0.4 161
17 COL1A1 rs2277632 A49G *ctctccctccctcctactc aatccagtactctcctgtgg 76.6 0.2 166
18 COL1A1 rs2075558 A48G *catttttcatcaccgactg agtaatggaggcaggaagat 75.8 0.2 168
19 COL2A1 rs2070739 A46G *cagtgtacgtgaacctgcta acctaccactgcaagaacag 76.5 0.3 168
20 COL2A1 rs2276454 T33C *tccaggtcttcagggaat tgagaggctgtaacctcagt 76.7 0.6 131
21 COL2A1 rs2276455 T61C *ggtgagatgaaggaacagg ctggtgatgaaggtttctgt 71.2 0.3 143
22 COL2A1 rs1635550 T57C *agaagtacctttgcccaatc caggaagaccctagacagaa 71.8 0.6 131
23 COL2A1 rs1635537 T94C *agaaacttgctttgccttct ctccttccctcctctgtact 72.5 0.3 166
24 COL2A1 rs1793958 T25C *gatcttgagctcttcattgc catgaggatatggaggtgac 71.9 0.3 142
25 COL11A1 rs2229783 T87C *gtctgagtacccattggaaa caagcagatgcagatgataa 67.3 0.3 157
26 COL11A1 rs3753841 T63C *attctagggtcctgttggtt aattggaaacattcactcca 70.2 0.2 151
27 COL11A1 rs2615987 T55G *tgaatatgcacccttttctt tgaacaccagaatttgaaca 66.6 0.4 155
For each target chosen, the consensus sequence and a known mutant sequence created by a single base-pair substitution were mixed, melted, and 
reannealed to create two homoduplexes and two heteroduplexes. For each target sequence, the designating number (#1, 2, 27), gene symbol, 
NCBI polymorphism reference number, specific mutation with its position in target fragment relative to the 5' end of the reverse primer, PCR 
primer sequences, average calculated melting temperature of the consensus homoduplex domain (including primer sequences), calculated change in 
melting temperature of the homoduplex due to the polymorphic base substitution and target fragment length without primers are shown. A 
thermally stable clamp sequence with a 5' fluorescent label (6-FAM) was synthesized separately for each test fragment incorporating the forward 
primer for each of the 27 target fragments. Clamp sequence: 6-FAM-CGCCC,GCCGC,GCCCC,GCGCC,CGTCC,CGCCG,CCCCC,GCCCG-
forward primer.Page 9 of 10
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